摘要
慢性肾脏病（chronic kidney disease,CKD）已成为全球的公共卫生问题,其发病率日益升高,且预后较差。矿物质代谢异常在CKD早期即可出现,患者如未得到及时的诊断和治疗。
出处
《诊断学理论与实践》
2011年第3期214-217,共4页
Journal of Diagnostics Concepts & Practice
参考文献16
-
1Covie A, Kothawala P, Bernal M, et al. Systematic review of the evidence underlying the association between mineral metabolism disturbances and risk of all-cause mortality, cardiovascular mortality and cardiovascular events in chronic kidney disease [J]. Nephrol Dial Transplant,2009,24(5): 1506-1523.
-
2Moe S, Drtieke T, Cunningham J, et al. Definition, evaluation, and classification of renal osteodystrophy: aposition statement from Kidney Disease: Improving Global Outcomes (KDIGO)[J]. Kidney Int,2006,69(11): 1945-1953.
-
3Martin K J, Olgaard K, Cobum JW, et al. Diagnosis, as- sessment, and treatment of bone turnover abnormalities in renal osteodystrophy [J]. Am J Kidney Dis,2004,43 (3): 558-565.
-
4Cunningham J, Sprague SM, Cannata-Andia J, et al. Os- teoporosis in chronic kidney disease[J]. Am J Kidney Dis, 2004,43(3):566-571.
-
5Moe SM. Vascular calcification and renal osteodystrophy relationship in chronic kidney disease [J]. Eur J Clin In- vest,2006,36(Suppl 2):51-62.
-
6Coen G, Bonucci E, Ballanti P, et al. PTH 1-84 and PTH "7-84" in the noninvasive diagnosis of renal bone disease [J]. Am J Kidney Dis,2002,40(2):348-354.
-
7Jamal SA, Hayden JA, Beyene J. Low bone mineral den- sity and fractures in long-term hemodialysis patients: a meta-analysis[J]. Am J Kidney Dis,2007,49(5):674-681.
-
8Johnson CA, McCarthy J, Bailie GR, et al. Analysis of renal bone disease treatment in dialysis patients[J]. Am J Kidney Dis,2002,39(6): 1270-1277.
-
9Martin K J, Gonzdlez EA. Metabolic bone disease in chronic kidney disease[J]. J Am Soc Nephrol,2007,18(3): 875-885.
-
10Wald R, Tentori F, Tighiouart H, et al. Impact of theKidney Disease Outcomes Quality Initiative (KDOQI) Clinical Practice Guidelines for Bone Metabolism and Disease in a large dialysis network [J]. Am J Kidney Dis, 2007,49(2):257-266.
同被引文献62
-
1俞育飞,朱萍.51例肾性骨病的病理研究[J].中华内科杂志,1993,32(7):448-450. 被引量：7
-
2<活性维生素D的合理应用>专家协作组.活性维生素D在慢性肾脏病继发性甲旁亢中合理应用的专家共识(修订版)[J].中华肾脏病杂志,2005,21(11):698-699. 被引量：97
-
3钱莹,陈楠,朱萍,汪关煜,王伟铭,李娅,冯伟.高转换型肾性骨病中骨保护素及其配体的表达和形态计量学观察[J].中华肾脏病杂志,2006,22(2):80-83. 被引量：1
-
4许艳芳,吴广文,刘献祥,万建新.肾性骨病的中西医治疗研究[J].福建中医药,2007,38(1):58-60. 被引量：3
-
5Ersoy FF. Osteoporosis in the elderly with chronic Kidney disease[J].International Urology and Nephrology,2007.321-331.
-
6Pelletier S,Roth H,Bouchet JL. Mineral and bone disease pattern in elderly haemodialysis patients[J].Nephrology Dialysis Transplantation,2010.3062-3070.
-
7Cannata-Andía JB,Rodriguez-García M,Román-García P. New therapies:calcimimetics,phosphate binders and vitamin D receptor activators[J].Pediatric Nephrology,2010.609-616.
-
8London G,Marchais S,Guerin A. Arterial hypertension,chronic renal insufficiency and dialysis[J].Nephrology,2007.S156-S161.
-
9Damment SJ,Pennick M. Systemic lanthanum is excreted in the bile of rats[J].Toxicology Letters,2007.69-77.
-
10Valdivielso JM,Cannata Andia JB,Coll B. A new role for the vitamin D receptor activation(VDRA) in chronic kidney disease[J].American Journal of Physiology-Renal Physiology,2009.F1502-F1509.
引证文献4
-
1钱莹,陈晓农,沈宇辉,朱萍,谢静运,陈楠.骨保护素及其配体检测在高转换型肾性骨病中的临床意义[J].诊断学理论与实践,2012,11(5):455-458.
-
2郭冬华,徐延琴,王海玲.慢性肾脏病代谢性骨病的研究进展[J].中华临床医师杂志（电子版）,2013,7(2):143-144. 被引量：1
-
3田艳.慢性肾脏病-矿物质和骨异常的发病机制与治疗进展[J].国际移植与血液净化杂志,2015,0(5):7-10. 被引量：4
-
4王余婷,曹媛茹,胡顺金.慢性肾脏病矿物质及骨代谢紊乱的中西医研究简况[J].中医药临床杂志,2016,28(9):1332-1334. 被引量：6
二级引证文献11
-
1李西林,唐小林,李军.慢性肾脏病-矿物质骨代谢紊乱的管理[J].名医,2020(12):20-21.
-
2王余婷,曹媛茹,胡顺金.慢性肾脏病矿物质及骨代谢紊乱的中西医研究简况[J].中医药临床杂志,2016,28(9):1332-1334. 被引量：6
-
3高小芳,常欢,陈航.维持性血液透析患者继发性甲状旁腺功能亢进的危险因素[J].贵州医科大学学报,2016,41(11):1330-1333. 被引量：11
-
4花侠玲.对CKD-MBD患者进行血清碱性磷酸酶和甲状旁腺激素检测的价值探讨[J].当代医药论丛,2017,15(22):195-196.
-
5刘桂萍,张林,张国领.慢性肾脏病—矿物质和骨异常的临床研究进展[J].中国医药导报,2018,15(3):34-37. 被引量：7
-
6刘洪,熊维建,熊燕影,邓星,郑新.郑新从“风”论治慢性肾脏病矿物质与骨异常经验[J].中医杂志,2018,59(10):825-828. 被引量：7
-
7闻君君.不同剂型骨化三醇治疗血液透析患者继发性甲状旁腺功能亢进的疗效[J].临床医学研究与实践,2018,3(23):14-16. 被引量：3
-
8左彦波,贾娟,王红杰.慢性肾脏病骨质疏松发病机制的研究进展[J].医学研究与教育,2019,36(4):10-18. 被引量：4
-
9张坤,余冠华,赵利,印南,王美.高通量透析对尿毒症中医证候积分与C-反应蛋白的影响[J].中医药临床杂志,2020,32(7):1290-1292.
-
10刘洪,熊维建,罗浩轩,龙梅,丁伟森,黎颖,钟锦.培元消癥方治疗慢性肾脏病5期透析合并CKD-MBD骨痛临床疗效研究[J].北京中医药大学学报,2021,44(7):650-658. 被引量：7
-
1柴瑛,殷文娟,刘晓宇.老年2型糖尿病患者骨密度及相关因素变化分析[J].中国误诊学杂志,2011,11(1):39-39. 被引量：4
-
2青湖.防骨质疏松哪些药不能吃[J].中华养生保健,2008(2):24-24.
-
3陈世清.甲状腺功能亢进与骨代谢的研究[J].医学综述,2002,8(8):478-479.
-
4李春红,田洁.继发性甲状旁腺功能亢进症的药物治疗进展[J].医学综述,2016,22(11):2171-2174. 被引量：6
